Cracking The Code: Understanding Analyst Reviews For Kymera Therapeutics
Cracking The Code: Understanding Analyst Reviews For Kymera Therapeutics
破譯代碼：了解kymera therapeutics的分析師評論
The standing of Kymera Therapeutics among financial experts...During the last three months, 7 analysts shared their evaluations of Kymera Therapeutics (NASDAQ:KYMR), revealing diverse outlooks from bullish to bearish.
在過去三個月中，有7位分析師分享了他們對kymera therapeutics (納斯達克:KYMR) 的評估結果，展現出看好到看淡不一的多樣化觀點。
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
以下表格總結了分析師們最近的評級，揭示了過去30天內情緒的變化並將其與前幾個月進行了比較。
Insights from analysts' 12-month price targets are revealed, presenting an average target of $48.86, a high estimate of $65.00, and a low estimate of $36.00. This upward trend is apparent, with the current average reflecting a 26.58% increase from the previous average price target of $38.60.
Insights from analysts' 12-month price targets are revealed, presenting an average target of $48.86, a high estimate of $65.00, and a low estimate of $36.00. This upward trend is apparent, with the current average reflecting a 26.58% increase from the previous average price target of $38.60.
Understanding Analyst Ratings: A Comprehensive Breakdown
分析師評級：全面解析
The standing of Kymera Therapeutics among financial experts...
通過對最近分析師...
登入免費觀看全文
登入/註冊